Home » Topics » Regulatory » Patents

Patents
RSS

Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham

Jan. 15, 1999

Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D

Jan. 15, 1999

Agouron's new MMP inhibitors described in patent literature

Jan. 15, 1999

Indole-based antimigraine agents in development at Allelix

Jan. 15, 1999

Cardioprotective benzoylguanidines with improved properties claimed by Hoechst

Jan. 15, 1999

Novel compounds developed at Roche for lipid disorders and fungal infections

Jan. 15, 1999

Vanadium complexes claimed by Angiotech for wide range of proliferative disorders

Jan. 14, 1999

Human mindin polypeptides and polynucleotides for angiogenic diseases

Jan. 14, 1999

Peripherally selective kappa-opioid agonists in early development at Warner-Lambert

Jan. 13, 1999

Novel condensed pyridazines claimed by Takeda for allergic conditions

Jan. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...